3.82
price down icon9.05%   -0.38
after-market After Hours: 3.76 -0.06 -1.57%
loading
Minerva Neurosciences Inc stock is traded at $3.82, with a volume of 131.92K. It is down -9.05% in the last 24 hours and up +81.90% over the past month. Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
See More
Previous Close:
$4.20
Open:
$4.15
24h Volume:
131.92K
Relative Volume:
0.05
Market Cap:
$26.71M
Revenue:
-
Net Income/Loss:
$-33.65M
P/E Ratio:
-0.8584
EPS:
-4.45
Net Cash Flow:
$-20.83M
1W Performance:
-15.67%
1M Performance:
+81.90%
6M Performance:
+124.71%
1Y Performance:
+45.80%
1-Day Range:
Value
$3.7707
$4.35
1-Week Range:
Value
$3.7707
$4.80
52-Week Range:
Value
$1.15
$12.46

Minerva Neurosciences Inc Stock (NERV) Company Profile

Name
Name
Minerva Neurosciences Inc
Name
Phone
617-600-7373
Name
Address
1601 TRAPELO ROAD, WALTHAM, MA
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
NERV's Discussions on Twitter

Compare NERV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NERV
Minerva Neurosciences Inc
3.82 29.37M 0 -33.65M -20.83M -4.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-08-20 Reiterated H.C. Wainwright Buy
May-14-20 Initiated BTIG Research Buy
Oct-02-19 Reiterated Chardan Capital Markets Buy
Sep-25-19 Initiated Chardan Capital Markets Buy
Sep-18-19 Initiated William Blair Outperform
May-31-19 Initiated H.C. Wainwright Buy
Sep-01-17 Initiated Citigroup Buy
Mar-06-17 Resumed Jefferies Buy
May-12-16 Resumed Jefferies Buy
View All

Minerva Neurosciences Inc Stock (NERV) Latest News

pulisher
Nov 03, 2025

Is Minerva Neurosciences Inc. (4MNA) stock positioned for secular growthJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Visualizing Minerva Neurosciences Inc. stock with heatmaps2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How buybacks impact Minerva Neurosciences Inc. stock valueMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Technical analysis overview for Minerva Neurosciences Inc. stockJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Volume Summary & Entry and Exit Point Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Minerva Neurosciences Inc. stock overvalued by current metrics2025 Market Outlook & Community Verified Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Minerva Neurosciences Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Minerva Neurosciences Inc. stock continue upward momentumMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 04:45:50 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Minerva Neurosciences Inc. stock sustain high P E ratiosJuly 2025 Summary & Daily Technical Forecast Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will earnings trigger a reversal in Minerva Neurosciences Inc.2025 Big Picture & Fast Gain Swing Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Multi asset correlation models including Minerva Neurosciences Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What to do if you’re stuck in Minerva Neurosciences Inc.IPO Watch & Accurate Technical Buy Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for Minerva Neurosciences Inc. explainedWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Heatmap analysis for Minerva Neurosciences Inc. and competitorsForecast Cut & High Win Rate Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Does Minerva Neurosciences Inc. stock trade at a discount to peers2025 Short Interest & Capital Efficiency Focused Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Minerva Neurosciences Inc. stock deliver shareholder valueTrade Exit Summary & Weekly High Return Forecasts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Analyzing net buyer seller activity in Minerva Neurosciences Inc.2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Volume spikes in Minerva Neurosciences Inc. stock – what they meanJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Minerva Neurosciences Inc. stock attractive for income investorsJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Automated trading signals detected on Minerva Neurosciences Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Combining machine learning predictions for Minerva Neurosciences Inc.Swing Trade & Daily Price Action Insights - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Minerva Neurosciences Inc. stock keep outperforming rivalsMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How interest rate cuts could boost Minerva Neurosciences Inc. stockProfit Target & Risk Managed Investment Strategies - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Minerva Neurosciences Inc. (4MNA) stock extend growth story2025 Dividend Review & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Visual analytics tools that track Minerva Neurosciences Inc. performanceEntry Point & Safe Capital Investment Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Minerva Neurosciences Inc. recovery potential after sell offJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - newser.com

Nov 01, 2025

Minerva Neurosciences Inc Stock (NERV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Cap:     |  Volume (24h):